retatrutide triple agonist How Does Work? Explained Retatrutide: The first-in-class investigational triple
Description
Its the weight loss doing the work, not some direct anti-inflammatory mechanism
Tirzepatide (dual GIP/GLP-1 agonist) sometimes produces different tolerability profiles than semaglutide alone
and optic nerve decompression surgery to try to relieve pressure on the optic nerve
Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds)
Compared to people taking bupropion-naltrexone, people taking a GLP-1 drug had a higher risk of pancreatitis, bowel obstruction and gastroparesis, the study found
